Status:
RECRUITING
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Lead Sponsor:
University of California, San Francisco
Conditions:
Metastatic Breast Cancer
Lobular Breast Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an IL...
Detailed Description
Primary Aims: 1. To evaluate the feasibility of developing a histologic based registry for participants living with metastatic lobular breast cancer. 2. To understand the natural history, treatment p...
Eligibility Criteria
Inclusion
- Histologically confirmed invasive lobular carcinoma. Mixed lobular/ductal cancer is allowed.
- Age \>=18 years
- Any receptor subtype.
- Ability to understand a written informed consent document, and the willingness to sign it.
Exclusion
- Stage I-III breast cancer.
- Lack of lobular histology on tumor biopsy.
- Other active cancer (prior treated cancer with no current evidence of disease is allowed).
Key Trial Info
Start Date :
December 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2034
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05964504
Start Date
December 20 2023
End Date
February 28 2034
Last Update
January 30 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Diego
San Diego, California, United States, 92053
2
University of California, San Francisco
San Francisco, California, United States, 94122
3
Abramson Cancer Center
Philadelphia, Pennsylvania, United States, 19104
4
MD Anderson Cancer Center
Houston, Texas, United States, 77030